Mounjaro (Tirzepatide) Auto-Inject Pen – For Research Purposes Only
Mounjaro (Tirzepatide) Auto-Inject Pen – For Research Purposes Only
Dual GLP-1/GIP Receptor Agonist — Auto-Inject Pen
Mounjaro (Tirzepatide) is a groundbreaking dual-action incretin mimetic that targets both GLP-1 and GIP receptors. Originally developed for type 2 diabetes research, it has demonstrated remarkable efficacy in weight management studies, making it one of the most significant research compounds in metabolic science.
Each auto-inject pen is pre-filled and ready for research use, featuring a precision dosing mechanism for accurate administration in laboratory settings.
Available Dosages
📊 Research Highlights
Clinical studies have shown Tirzepatide to reduce body weight by up to 22.5% in participants over 72 weeks. Its dual-action mechanism provides superior glycaemic control compared to single-receptor agonists.
⚠️ Research Use Only: This product is strictly for research purposes and is NOT intended for human consumption. Not for diagnosis, treatment, cure, or prevention of any disease. Must be 18+ to purchase.
🚚 Shipping
UK Mainland: £7.50 — Royal Mail Next Day Delivery
Ireland & Northern Ireland: £10.50 — Royal Mail Next Day Delivery
